Advertisement

Addressing the Question: Phototherapy and the Risk of Skin Cancer

  • John Koo
  • Mio Nakamura
Chapter
Part of the Clinical Cases in Dermatology book series (CLIDADE)

Abstract

Given that UVA and UVB from natural sunlight are known to be carcinogenic to the skin, the main safety question for dermatologists and patients alike is the risk of skin malignancy of phototherapy. UVB phototherapy appears not to have any increased risk of melanoma and nonmelanoma skin cancer. There is evidence of an increased risk of developing non-melanoma skin cancer with more than 250 treatments of PUVA in fair-skinned Caucasian individuals. The risk of genital skin cancers with UVB and PUVA are unclear, and therefore, genital shielding should be routinely practiced.

Keywords

Skin Cancer Natural Sunlight Skin Malignancy Nonmelanoma Skin Cancer Chronic Plaque Psoriasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Wang E, Sasaki J, Nakamura M, Koo J. Cutaneous carcinogenic risk of phototherapy: an updated comprehensive review. J Psoriasis and Psoriatic Arth. 2015;1(1):44–51.Google Scholar
  2. 2.
    Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol. 1988;91(2):120–4.CrossRefPubMedGoogle Scholar
  3. 3.
    Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis Photochemotherapy follow-up study. Cancer. 1994;73(11):2759–64.CrossRefPubMedGoogle Scholar
  4. 4.
    Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of non-melanoma skin cancer. PUVA follow-up study. J Natl Cancer Inst. 1998;90(17):1278–84.CrossRefPubMedGoogle Scholar
  5. 5.
    Katz KA, Marcil I, Stern RS. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients. J Invest Dermatol. 2002;118(6):1038–43.CrossRefPubMedGoogle Scholar
  6. 6.
    Stern RS, Zierler S, Parrish JA. Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation. Lancet. 1980;1(8171):732–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Lim JL, Stern RS. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in Psoralen and ultraviolet A-treated patients. J Invest Dermatol. 2005;124(3):505–13.CrossRefPubMedGoogle Scholar
  8. 8.
    Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med. 1990;322(16):1093–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol. 2001;45:649–61.CrossRefPubMedGoogle Scholar
  10. 10.
    Lee E, Koo J, Berger T. UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol. 2005;44(5):355–60.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • John Koo
    • 1
  • Mio Nakamura
    • 1
  1. 1.Psoriasis and Skin Treatment Center, Department of DermatologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations